Literature DB >> 23226809

8-Chloroadenosine 3',5'-monophosphate induces cell cycle arrest and apoptosis in multiple myeloma cells through multiple mechanisms.

Yi-Min Cheng1, Qi Zhu, Yi-Yun Yao, Yong Tang, Ming-Ming Wang, Li-Fang Zou.   

Abstract

The aim of this study was to investigate the molecular mechanism of 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) in the inhibition of the growth and induction of apoptosis of multiple myeloma (MM) cells. Two MM-derived cell lines, RPMI-8226 and U266, were used. Cell viability, apoptosis induction and mitochondrial transmembrane potential were determined and the expression levels of cell cycle regulatory proteins (Cdk2, cyclin E, p27 and c-myc) and p38 mitogen-activated protein kinase (MAPK) protein were detected. Following treatment with 8-Cl-cAMP, the percentage of apoptotic cells increased in a concentration- and time-dependent manner and the mitochondrial transmembrane potential collapsed to reveal typical apoptotic features. Our data further demonstrated that 8-Cl-cAMP induced progressive phosphorylation of p38 MAPK and that the expression levels of p27 proteins in the MM cells were increased whereas those of c-myc were significantly decreased. Notably, the proapoptotic effect of 8-Cl-cAMP was largely prevented by a p38 MAPK inhibitor. Furthermore, knockdown of p27 was able to decrease the 8-Cl-cAMP-induced apoptosis in the MM cells. These results indicate that 8-Cl-cAMP induced p27-dependent cell cycle arrest and apoptosis in the MM cells, which demonstrates the potential of cAMP-modulating agents for use in the treatment of MM.

Entities:  

Year:  2012        PMID: 23226809      PMCID: PMC3506740          DOI: 10.3892/ol.2012.905

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  42 in total

Review 1.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Bcl-xl expression in multiple myeloma.

Authors:  S D P W M Peeters; S Hovenga; S Rosati; E Vellenga
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 3.  How best to use new therapies in multiple myeloma.

Authors:  David Dingli; S Vincent Rajkumar
Journal:  Blood Rev       Date:  2010-04-01       Impact factor: 8.250

4.  A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.

Authors:  Ming-Jer Huang; Yuan-chih Cheng; Chien-Ru Liu; Shufan Lin; H Eugene Liu
Journal:  Exp Hematol       Date:  2006-11       Impact factor: 3.084

Review 5.  Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

Authors:  Y S Cho-Chung
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

6.  The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.

Authors:  Xiaoli Feng; Jie Yan; Yibiao Wang; Juleen R Zierath; Magnus Nordenskjöld; Jan-Inge Henter; Bengt Fadeel; Chengyun Zheng
Journal:  Mol Immunol       Date:  2010-06-09       Impact factor: 4.407

7.  Analysis of cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women with premature ovarian failure.

Authors:  Binbin Wang; Feng Ni; Lin Li; Zhaolian Wei; Xianglong Zhu; Jing Wang; Yunxia Cao; Xu Ma
Journal:  Reprod Biomed Online       Date:  2010-04-27       Impact factor: 3.828

8.  Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

Authors:  D T Vistica; P Skehan; D Scudiero; A Monks; A Pittman; M R Boyd
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

9.  Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

Authors:  M Pettersson; H Jernberg-Wiklund; L G Larsson; C Sundström; I Givol; Y Tsujimoto; K Nilsson
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

10.  Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes.

Authors:  Kathleen Ponzetti; Melissa King; Anna Gates; M Sawkat Anwer; Cynthia Rl Webster
Journal:  Hepat Med       Date:  2010-01
View more
  3 in total

1.  The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.

Authors:  Alessandra Dicitore; Elisa Stellaria Grassi; Michele Caraglia; Maria Orietta Borghi; Germano Gaudenzi; Leo J Hofland; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

2.  cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance.

Authors:  Yingying Wang; Yong Tang; Haifang Hang; Mingming Wang; Yuyang Pang; Yehua Yu; Yingli Wu; Qi Zhu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

Review 3.  Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev; Ksenia Matlawska-Wasowska
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.